Skip to content
naulon
Not checkedNot checked for notices yet.

Bitter gourd, Momordica charantia L., breeding lines differ in secondary metabolite content according to market type

Bernhard Trierweiler, Matthias A. Frechen, Sebastian T. Soukup and 6 more

Journal of Applied Botany and Food Quality · 2019

doi:10.5073/jabfq.2019.092.015 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Bitter gourd, Momordica charantia L., is an important commercial cucurbitaceous vegetable of enormous medicinal value in Asia because of its secondary metabolite content. We report here the characterization and evaluation of open-pollinated (OP) edible South Asian and Southeast Asian types of bitter gourd breeding lines, developed at the World Vegetable Center, for horticultural traits (11 OP) and secondary metabolites (10 OP) and their comparisons with commercial OP and F1 hybrid cultivars. Marketable yields of South Asian and Southeast Asian type breeding lines were comparable to the OP ‘BARI Karella 1’ and the hybrid ‘Benteng’, respectively. The bitter gourd cultivars and breeding lines included in this study exhibited specific patterns for five secondary metabolites (saponins, carotenoids, chlorophyll a and b, and vitamin C): in general the two cultivars and South Asian type breeding lines contained higher levels of secondary metabolites, e.g. carotenoids, than the Southeast Asian bitter gourd breeding lines. Some of these bitter gourd lines will be released to Asian home and school gardeners after conducting multi-location trials across Asia to improve vegetable consumption as a main task of bitter gourd breeding.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.